These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11110053)

  • 1. Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome.
    Zunarelli E; Nicoll JA; Migaldi M; Trentini GP
    Breast Cancer Res Treat; 2000 Oct; 63(3):193-8. PubMed ID: 11110053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism and central nervous system tumors: correlation with cell proliferation indices and clinical outcome.
    Zunarelli E; Nicoll JA; Trentini GP
    Clin Neuropathol; 2000; 19(1):1-6. PubMed ID: 10774944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan.
    Chang NW; Chen DR; Wu CT; Aouizerat BE; Chen FN; Hung SJ; Wang SH; Wei MF; Chang CS
    Breast Cancer Res Treat; 2005 Apr; 90(3):257-61. PubMed ID: 15830139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
    Frolik D; Caduff R; Varga Z
    Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIB-1 proliferative activity in invasive breast cancer measured by image analysis.
    Querzoli P; Albonico G; Ferretti S; Rinaldi R; Magri E; Indelli M; Nenci I
    J Clin Pathol; 1996 Nov; 49(11):926-30. PubMed ID: 8944614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.
    Pich A; Margaria E; Chiusa L; Candelaresi G; Dal Canton O
    Br J Cancer; 1999 Feb; 79(5-6):959-64. PubMed ID: 10070897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ER, PR, MIB-1, pS2, and nuclear grade in FNA specimens of cT1 breast carcinomas: clinicopathological correlation.
    Angelidou E; Politi E; Sotiropoulou G; Poulianou E; Koutselini H
    Diagn Cytopathol; 2006 Aug; 34(8):547-52. PubMed ID: 16850494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the proliferation rate on the course of node negative breast carcinoma].
    Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma.
    Spiethoff A; Schenck A; Bohrer M
    J Cancer Res Clin Oncol; 2000 Dec; 126(12):707-10. PubMed ID: 11153143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
    Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple index using video image analysis to predict disease outcome in primary breast cancer.
    Lockwood CA; Ricciardelli C; Raymond WA; Seshadri R; McCaul K; Horsfall DJ
    Int J Cancer; 1999 Jun; 84(3):203-8. PubMed ID: 10371334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
    Soslow RA; Carlson DL; Horenstein MG; Osborne MP
    Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
    MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
    Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese.
    Chang SJ; Hou MF; Tsai SM; Kao JT; Wu SH; Hou LA; Tsai LY
    Breast Cancer Res Treat; 2006 Jul; 98(1):109-13. PubMed ID: 16752225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
    Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
    Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.